Anagenics (ASX:AN1) is pleased to advise that it has appointed Matthew Dudek as Acting Chief Executive Officer, effective 28 February 2022 | Read the full announcement: https://t.co/9mIudQAvc7 $AN1
How is Anagenics going following the lockdown? CEO Maria Halasz breaks down the revenue drivers of the business and how external conditions affected key drivers | Learn more: https://t.co/8YRZEbeUyp $AN1
Anagenics CEO and Managing Director Maria Halasz writes, "Mentoring isn’t enough. We need real advocacy and commitments for change at all levels" - Women's Agenda reports | Read more: https://t.co/gZobCV5hTQ $AN1
How to integrate two businesses under one roof? Take a 51 second masterclass by CEO Maria Halasz as she talks about the acquisition of BLC Cosmetics | Find out more: https://t.co/8YRZEbfsnX $AN1
Anagenics acquired BLC Cosmetics late last year to accelerate revenue growth. Hear CEO of Anagenics, Maria Halasz, talk about how the BLC acquisition helped scale the business. | Learn more: https://t.co/8YRZEbeUyp $AN1
Anagenics will be supplying a full range of hair growth products with its FGF5 inhibitor exclusively to Original & Mineral professional hair products | Read more: https://t.co/23f5JEaQ2O $AN1
Cellmid (ASX:CDY) becomes Anagenics (ASX:AN1) after shareholders approve a new name for the health and beauty-tech business. The new name was inspired by the Greek word for regeneration: anagennisi | ASX announcement: https://t.co/hix29xg017 $CDY $AN1
Who is AN1? With our brand new name Anagenics, we now have a brand new ASX code! It has changed from CDY to AN1 — so update your watchlists and portfolios, there’s a new ticker in town | Read the announcement: https://t.co/hix29xg017
Cellmid has changed its name to Anagenics Limited Inspired by the Greek word for regeneration – anagennisi – the name change also references anagen, the growth phase of the hair cycle targeted by the company’s proprietary FGF5 inhibitor technology | Read: https://t.co/VpxR21ZHd3
Anagenics is here! Much like the way our patented FGF5 inhibitor technology targets the anagen phase of hair growth to regenerate a healthy hair cycle. You can read more about our technology on our brand new Anagenics website | Check it out here: https://t.co/8YRZEbeUyp
A new name means a new logo! Our new name, Anagenics, comes from the Greek word for regeneration: anagennisi! | Read all about the new name change in our announcement: https://t.co/hix29xg017
Cellmid's Managing Director and CEO, Maria Halasz, recently sat down with Information Age to talk about the skills shortage in Australia and finding skilled staff in beauty-tech | See the article: https://t.co/p7gm7ig80f $CDY
Cellmid CEO Maria Halasz is on A Current Affair to discuss évolis, a pioneering anti-ageing hair care collection that uses natural actives and antioxidants | Watch now: https://t.co/XeBZNBd4tD $CDY
The core underlying technology for Cellmid's évolis brand, the FGF5 inhibition technology, is clinically tested and validated. This technology has been shown to reduce hairfall and increase the number of actively growing hair follicles | https://t.co/Ymfz38lPTt $CDY
In case you missed it! Watch Cellmid CEO Maria Halasz on A Current Affair talking about évolis' drug-free and natural ingredients | Watch now: https://t.co/XeBZNBd4tD $CDY
Cellmid received $500K in research and development tax credit for the 2021 financial year. The tax credit is an important contributor to the Company’s ability to fund its ongoing research and development of technologies and development of new products https://t.co/3CYqVr84bs $CDY
Did you know? Cellmid is minimising its contributions to landfill through the use of recyclable materials in our packaging and participating in industry funded recycling schemes like Der Gruner Punkt in Germany. | Learn more: https://t.co/EoWgG4rK4u $CDY #beauty#cosmetics
We are excited to have completed the BLC Cosmetics acquisition and broaden our product portfolio offerings with 11 premium anti-aging and wellness brands. | Learn more: https://t.co/EoWgG4rK4u $CDY #beauty#cosmetics#antiaging#acqusition#consumerhealth
Cellmid completed the acquisition of 100% of BLC Cosmetics in a deal including cash and shares with strong support from shareholders. | Learn more: https://t.co/EoWgG4rK4u $CDY #beauty#cosmetics#antiaging#acqusition#consumerhealth
Highly accomplished investment professional, Phillip Christopher has been appointed as Cellmid's non-executive director. Phillip has been responsible for advising and guiding private investments including BLC Cosmetics prior to its acquisition by CDY: https://t.co/T0W3VYiHSY $CDY